Computational design of high-performance ligand for enantioselective Markovnikov hydroboration of aliphatic terminal alkenes

by Hiroaki Iwamoto, Tsuneo Imamoto, Hajime Ito
Published 2018-06-01

Is the C-C Motif Ligand 2–C-C Chemokine Receptor 2 Axis a Promising Target for Cancer Therapy and Diagnosis?

by Hiroaki Iwamoto, Kouji Izumi, Atsushi Mizokami
Published 2020-12-01

Prognosis of patients with prostate cancer and middle range prostate - specific antigen levels of 20 – 100 ng / mL

by Hiroaki Iwamoto, Kouji Izumi, Yoshifumi Kadono, Atsushi Mizokami

Treatment Strategies for High-Risk Localized and Locally Advanced and Oligometastatic Prostate Cancer

by Tomoyuki Makino, Kouji Izumi, Hiroaki Iwamoto, Atsushi Mizokami
Published 2021-09-01

Efficacy of two-time prophylactic intravenous administration of tazobactam/piperacillin for transrectal ultrasound-guided needle biopsy of the prostate

by Hiroaki Iwamoto, Kazuyoshi Shigehara, Tohru Miyagi, Takao Nakashima, Masayoshi Shimamura, Mikio Namiki
Published 2015-09-01

Testosterone Replacement Therapy for Patients with Hypogonadism after High Dose-Rate Brachytherapy for High-Risk Prostate Cancer: A Report of Six Cases and Literature Review

by Suguru Kadomoto, Kazuyoshi Shigehara, Hiroaki Iwamoto, Hiroshi Yaegashi, Kouji Izumi, Yoshifumi Kadono, Atsushi Mizokami
Published 2020-01-01

A novel screening strategy for clinically significant prostate cancer in elderly men over 75 years of age

by Hiroaki Iwamoto, Kouji Izumi, Suguru Kadomoto, Tomoyuki Makino, Renato Naito, Hiroshi Yaegashi, Kazuyoshi Shigehara, Yoshifumi Kadono, Atsushi Mizokami
Published 2021-01-01

Androgen replacement therapy for cancer‐related symptoms in male: result of prospective randomized trial (ARTFORM study)

by Kouji Izumi, Hiroaki Iwamoto, Hiroshi Yaegashi, Takahiro Nohara, Kazuyoshi Shigehara, Yoshifumi Kadono, Shigeki Nanjo, Tadaaki Yamada, Koshiro Ohtsubo, Seiji Yano, Atsushi Mizokami
Published 2021-08-01

Tumor-Associated Macrophages Induce Migration of Renal Cell Carcinoma Cells via Activation of the CCL20-CCR6 Axis

by Suguru Kadomoto, Kouji Izumi, Kaoru Hiratsuka, Taito Nakano, Renato Naito, Tomoyuki Makino, Hiroaki Iwamoto, Hiroshi Yaegashi, Kazuyoshi Shigehara, Yoshifumi Kadono, Hiroki Nakata, Yohei Saito, Kyoko Nakagawa-Goto, Atsushi Mizokami
Published 2019-12-01

Reply to Comment on “Kadomoto, S. et al. Tumor-Associated Macrophages Induce Migration of Renal Cell Carcinoma Cells via Activation of the CCL20-CCR6 Axis” Cancers 2020 12, 89

by Suguru Kadomoto, Kouji Izumi, Kaoru Hiratsuka, Taito Nakano, Renato Naito, Tomoyuki Makino, Hiroaki Iwamoto, Hiroshi Yaegashi, Kazuyoshi Shigehara, Yoshifumi Kadono, Hiroki Nakata, Yohei Saito, Kyoko Nakagawa-Goto, Atsushi Mizokami
Published 2020-02-01

A novel risk classification score for malignant ureteral obstruction: a multicenter prospective validation study

by Kouji Izumi, Takashi Shima, Kazuyoshi Shigehara, Kiyoshi Sawada, Renato Naito, Yuki Kato, Mitsuo Ofude, Hiroshi Kano, Hiroaki Iwamoto, Hiroshi Yaegashi, Kazufumi Nakashima, Masashi Iijima, Shohei Kawaguchi, Takahiro Nohara, Yoshifumi Kadono, Atsushi Mizokami
Published 2021-02-01

Anti-proliferative and anti-migratory properties of coffee diterpenes kahweol acetate and cafestol in human renal cancer cells

by Tomoyuki Makino, Kouji Izumi, Kaoru Hiratsuka, Hiroshi Kano, Takashi Shimada, Taito Nakano, Suguru Kadomoto, Renato Naito, Hiroaki Iwamoto, Hiroshi Yaegashi, Kazuyoshi Shigehara, Yoshifumi Kadono, Hiroki Nakata, Yohei Saito, Kyoko Nakagawa-Goto, Norihiko Sakai, Yasunori Iwata, Takashi Wada, Atsushi Mizokami
Published 2021-01-01